(3-(2-Methoxyquinolin-6-yl)quinoxalin-6-yl)(piperidin-1-yl)methanone

ID: ALA5220930

Chembl Id: CHEMBL5220930

PubChem CID: 135300464

Max Phase: Preclinical

Molecular Formula: C24H22N4O2

Molecular Weight: 398.47

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2cc(-c3cnc4ccc(C(=O)N5CCCCC5)cc4n3)ccc2n1

Standard InChI:  InChI=1S/C24H22N4O2/c1-30-23-10-7-16-13-17(5-8-19(16)27-23)22-15-25-20-9-6-18(14-21(20)26-22)24(29)28-11-3-2-4-12-28/h5-10,13-15H,2-4,11-12H2,1H3

Standard InChI Key:  BFJFBRZCGXOIEP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5220930

    ---

Associated Targets(Human)

HPGD Tchem 15-hydroxyprostaglandin dehydrogenase [NAD+] (24926 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 398.47Molecular Weight (Monoisotopic): 398.1743AlogP: 4.48#Rotatable Bonds: 3
Polar Surface Area: 68.21Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.18CX LogP: 4.07CX LogD: 4.07
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.51Np Likeness Score: -1.43

References

1. Hu B, Toda K, Wang X, Antczak MI, Smith J, Geboers S, Nishikawa G, Li H, Dawson D, Fink S, Desai AB, Williams NS, Markowitz SD, Ready JM..  (2022)  Orally Bioavailable Quinoxaline Inhibitors of 15-Prostaglandin Dehydrogenase (15-PGDH) Promote Tissue Repair and Regeneration.,  65  (22.0): [PMID:36322935] [10.1021/acs.jmedchem.2c01299]

Source